Mitochondrial damage revealed by morphometric and semiquantitative analysis of mouse pup cardiomyocytes following in utero and postnatal exposure to zidovudine and lamivudine

Toxicological Sciences : an Official Journal of the Society of Toxicology
Jack B BishopAbraham Nyska

Abstract

Zidovudine (ZDV), an antiretroviral drug used alone or in combination with other antiretroviral agents to treat HIV-infected pregnant women and their newborn infants, effectively reduces mother-to-child transmission of the virus. That myopathy and cardiomyopathy, related to mitochondrial damage, develop in some adults chronically treated with ZDV has long been known; recently, reports have suggested that similar adverse effects may occur in some infants exposed perinatally. Using a mouse model of human neonatal exposure, we treated pregnant CD-1 mice twice daily with doses of 75 mg/kg ZDV plus 37.5 mg/kg lamivudine throughout gestation and lactation; pups were exposed by direct gavage beginning postnatal day (PND) 4 and sacrificed on PND 28. Hearts were removed rapidly, and ventricles were processed for electron microscopy. Morphometric and semiquantitative morphological analyses were performed on three micrographs from each of three blocks from each of three females and three males from the control and treated groups. Treated mice showed significant increases in the mean area and decreases in the mean number of cardiomyocytic mitochondria compared to controls. We observed clusters of damaged mitochondria more frequently in tre...Continue Reading

Citations

Jun 7, 2013·The New England Journal of Medicine·Thierry VilbouxRaz Somech
May 11, 2007·Toxicological Sciences : an Official Journal of the Society of Toxicology·June K DunnickGregory S Travlos
Dec 15, 2010·Journal of Perinatal Medicine·D Heather WattsColeen K Cunningham
Nov 13, 2014·Expert Opinion on Drug Safety·Marilia Santini-Oliveira, Beatriz Grinsztejn
Jan 5, 2011·Toxicology and Applied Pharmacology·Qiangen WuJia-Long Fang
Jun 19, 2009·Toxicologic Pathology·Eliahu GolombHerzl Schwalb
Sep 7, 2018·Journal of Cellular Biochemistry·Jessy J FadelKarim S Echtay
Mar 16, 2007·Environmental and Molecular Mutagenesis·Vernon E Walker, Miriam C Poirier
Jan 6, 2006·Environmental and Molecular Mutagenesis·Sherine S L ChanJack B Bishop
May 23, 2012·Critical Care Medicine·Lonneke SmedingClaudia C dos Santos
Apr 18, 2013·Clinical and Molecular Hepatology·Eun Hye KimKwang-Hyub Han

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.